1. Home
  2. PCN vs PAHC Comparison

PCN vs PAHC Comparison

Compare PCN & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pimco Corporate & Income Strategy Fund

PCN

Pimco Corporate & Income Strategy Fund

HOLD

Current Price

$12.85

Market Cap

846.9M

Sector

Finance

ML Signal

HOLD

Logo Phibro Animal Health Corporation

PAHC

Phibro Animal Health Corporation

HOLD

Current Price

$39.55

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCN
PAHC
Founded
2001
1946
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
846.9M
1.6B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
PCN
PAHC
Price
$12.85
$39.55
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
$31.25
AVG Volume (30 Days)
218.7K
261.7K
Earning Date
01-01-0001
02-04-2026
Dividend Yield
9.73%
1.21%
EPS Growth
N/A
288.74
EPS
N/A
1.67
Revenue
N/A
$1,399,676,000.00
Revenue This Year
N/A
$15.34
Revenue Next Year
N/A
$3.28
P/E Ratio
N/A
$23.67
Revenue Growth
N/A
33.72
52 Week Low
$10.70
$16.16
52 Week High
$14.48
$46.42

Technical Indicators

Market Signals
Indicator
PCN
PAHC
Relative Strength Index (RSI) 61.45 50.94
Support Level $12.66 $36.47
Resistance Level $12.82 $38.49
Average True Range (ATR) 0.07 1.41
MACD 0.03 0.20
Stochastic Oscillator 92.52 61.28

Price Performance

Historical Comparison
PCN
PAHC

About PCN Pimco Corporate & Income Strategy Fund

PIMCO Corporate & Income Strategy Fund is a closed-end management investment company. Its objective is to seek high current income with capital appreciation as a secondary objective. It invests in corporate bonds and notes, non-agency mortgage-backed securities, asset-backed securities, short-term instruments, and others.

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Share on Social Networks: